Real-world outcomes of patients with advanced-stage hepatocellular carcinoma receiving combination therapy with atezolizumab and bevacizumab: A South Australian statewide experience

被引:0
|
作者
Chan, A. [1 ,2 ]
Saluja, H. [1 ]
Nind, G. [3 ]
Singhal, N. [1 ]
Roy, A. [4 ]
Mcgregor, M. [2 ]
Chinnaratha, A. [2 ]
机构
[1] Royal Adelaide Hosp, Adelaide, SA, Australia
[2] Lyell McEwin Hosp, Adelaide, SA, Australia
[3] Queen Elizabeth Hosp, Adelaide, SA, Australia
[4] Flinders Med Ctr, Adelaide, SA, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
118
引用
收藏
页码:56 / 57
页数:2
相关论文
共 50 条
  • [41] Real-world treatment management of patients with advanced-stage classic Hodgkin lymphoma receiving front line therapy
    Avigdor, A.
    Trinchese, F.
    Gavini, F.
    Bent-Ennakhil, N.
    Dalal, M.
    Zomas, A.
    Broun, S. Gettner
    Gini, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S649 - S650
  • [42] Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States
    Singal, Amit G.
    Ozgurdal, Kirhan
    Fan, Xiaozhou
    Vassilev, Zdravko
    Pan, Xiaoyun
    Multani, Jasjit K.
    Chen, Chi-Chang
    Zhou, Zifan
    He, Jing
    Pisa, Federica
    CANCERS, 2023, 15 (23)
  • [43] Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma
    Hwang, Sang Youn
    Woo, Hyun Young
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Ki Youn
    Lee, Yu Rim
    Park, Soo Young
    Chung, Woo Jin
    Jang, Byoung Kuk
    Tak, Won Young
    CANCERS, 2024, 16 (04)
  • [44] Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
    de Castro, Tiago
    Welland, Sabrina
    Jochheim, Leonie
    Leyh, Cathrine
    Shmanko, Kateryna
    Finkelmeier, Fabian
    Jeliazkova, Petia
    Jefremow, Andre
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Roessler, Daniel
    Ben Khaled, Najib
    Enssle, Stefan
    Venerito, Marino
    Fruendt, Thorben W.
    Schultheiss, Michael
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Wirth, Thomas C.
    Marquardt, Jens U.
    Greil, Richard
    Fricke, Christina
    Guenther, Rainer
    Schmiderer, Andreas
    Bettinger, Dominik
    Wege, Henning
    Scheiner, Bernhard
    Mueller, Martina
    Strassburg, Christian P.
    Siebler, Juergen
    Ehmer, Ursula
    Waidmann, Oliver
    Weinmann, Arndt
    Pinter, Matthias
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
  • [45] Clinical Outcomes of Ramucirumab as Post-treatment Following Atezolizumab/Bevacizumab Combination Therapy in Advanced Hepatocellular Carcinoma
    Kuzuya, Teiji
    Kawabe, Naoto
    Hashimoto, Senju
    Funasaka, Kohei
    Nagasaka, Mitsuo
    Nakagawa, Yoshihito
    Miyahara, Ryoji
    Shibata, Tomoyuki
    Takahara, Takeshi
    Kato, Yutaro
    Sugioka, Atsushi
    Hirooka, Yoshiki
    ANTICANCER RESEARCH, 2022, 42 (04) : 1905 - 1910
  • [46] Evans’ syndrome induced by atezolizumab plus bevacizumab combination therapy in advanced hepatocellular carcinoma
    Masanori Fukushima
    Kazuaki Tajima
    Ryu Sasaki
    Yasuhiko Nakao
    Kosuke Takahashi
    Eisuke Ozawa
    Satoshi Miuma
    Takeharu Kato
    Hisamitsu Miyaaki
    Kazuhiko Nakao
    Clinical Journal of Gastroenterology, 2023, 16 : 402 - 406
  • [47] Evans' syndrome induced by atezolizumab plus bevacizumab combination therapy in advanced hepatocellular carcinoma
    Fukushima, Masanori
    Tajima, Kazuaki
    Sasaki, Ryu
    Nakao, Yasuhiko
    Takahashi, Kosuke
    Ozawa, Eisuke
    Miuma, Satoshi
    Kato, Takeharu
    Miyaaki, Hisamitsu
    Nakao, Kazuhiko
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (03) : 402 - 406
  • [48] Polymyalgia rheumatica during combination therapy with atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
    Naoki Dosoden
    Teiji Kuzuya
    Yumi Ito
    Jo Nishino
    Eizaburo Ohno
    Naoto Kawabe
    Senju Hashimoto
    Yoshiki Hirooka
    Hidekata Yasuoka
    Clinical Journal of Gastroenterology, 2023, 16 : 567 - 571
  • [49] Polymyalgia rheumatica during combination therapy with atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
    Dosoden, Naoki
    Kuzuya, Teiji
    Ito, Yumi
    Nishino, Jo
    Ohno, Eizaburo
    Kawabe, Naoto
    Hashimoto, Senju
    Hirooka, Yoshiki
    Yasuoka, Hidekata
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (04) : 567 - 571
  • [50] Atezolizumab and bevacizumab with anticoagulant or antiplatelet therapy in hepatocellular carcinoma patients: Real-world data for informed clinical decision-making
    Villeret, Francois
    Nahon, Pierre
    LIVER INTERNATIONAL, 2024, 44 (08) : 1749 - 1750